A story built from the name spironolactone itself - so the mechanism of action, key side effects, and the way Step 1 actually tests it stick on the first read.

A 71-year-old woman with HFrEF and an eGFR of 38 is on lisinopril and metoprolol. Spironolactone is added. Two weeks later, she presents with fatigue and a wide-complex bradycardia. The most likely contributor is:
Spironolactone is a competitive aldosterone receptor antagonist that blocks sodium reabsorption and potassium excretion in the collecting duct, making it a potassium-sparing diuretic. The primary risk is hyperkalemia, which becomes especially dangerous when combined with ACE inhibitors or ARBs in patients with reduced GFR. It also blocks androgen receptors, causing gynecomastia and menstrual irregularities — useful clinically for PCOS and hirsutism. Spironolactone reduces mortality in heart failure with reduced ejection fraction and is first-line for managing cirrhotic ascites.
Every Monday, one new drug. Story, mnemonic, and practice question. Completely free.